| Previous Close | 0.1200 |
| Open | 0.1200 |
| Bid | 0.1150 x N/A |
| Ask | 0.1200 x N/A |
| Day's Range | 0.1150 - 0.1250 |
| 52 Week Range | 0.0650 - 0.2500 |
| Volume | 1,144,937 |
| Avg. Volume | 1,610,902 |
| Market Cap | 26.469M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0560 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Newsfile
Red Light Holland Announces Change to Virtual Annual Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - November 24, 2020) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) ("Red Light Holland" or the "Company") today announces that its Annual and General Meeting of shareholders scheduled for Monday, November 30, 2020 will be held virtually due to the coronavirus (COVID-19) pandemic.Due to the current COVID-19 lockdown in Toronto and in recognition of the latest directives and guidance from public health authorities and the Provincial ...
- Newsfile
Red Light Holland and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market
Toronto, Ontario--(Newsfile Corp. - November 20, 2020) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) ("Red Light Holland"), and Halo Labs Inc. ("Halo") (NEO: HALO) (OTC: AGEEF) (Germany: A9KN) are pleased to announce they have entered into a non-binding letter of intent for the purposes of creating a joint venture to become a licensed psilocybin manufacturer to supply psilocybin products to licensed service centers in the State of Oregon, and to ...
- Newsfile
Red Light Holland Engages RadixMotion to Develop iMicrodose Digital Care Program Using Latest Immersive Technology
Toronto, Ontario--(Newsfile Corp. - November 17, 2020) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) ("Red Light Holland" or the "Company") is pleased to announce that via its Scarlette Lillie Science and Innovation division, it has engaged RadixMotion Inc. ("RadixMotion"), an immersive technology company based in the State of Delaware, to design and develop a digital care program for people exploring microdosing. The program will accompany customers from the first time they encounter ...
